
AZ boasts phase 3 win for self-administered gMG drug
Alexion has announced high-level positive results from a phase 3 trial of gefurulimab, a once-weekly self-administered treatment for gMG.

mRNA ‘wake-up call’ shows promise as universal cancer vaccin...
Researchers at the University of Florida have developed a new mRNA-based vaccine that, when combined with checkpoint inhibitor immunotherapy, significantly boosted anti-tumour activit

EC clears first treatment for high-risk smouldering multiple...
Johnson & Johnson’s Janssen-Cilag has secured European Commission approval for a new indication of its subcutaneous formulation of DARZALEX

RFK Jr formally backs thimerosal ban in US vaccines
HHS Secretary Robert F Kennedy Jr has formally signed off on a recommendation to remove thimerosal from all flu vaccines in the US

European Commission approves 2nd IPCEI to sum of €403m
The European Commission has approved, under EU State aid rules, the second health-related IPCEI to support innovations in medical devices.
Partner Content

Revolutionising Clinical Trials: Evolution Summit 2025 Retur...
Marcus Evans is proud to announce the Evolution Summit September 2025, an exclusive, invitation-only event bringing together leading clinical trial executives, innovative suppliers

Welcome to the 3rd Spatial Biology for Drug Development Summ...
Transforming Research & Development with Faster, More Precise Spatial Insights

2nd Hit ID Summit
Why prioritise your hit discovery game? Finding the right chemical start points is crucial to help you save time and costs in the long run.

Unlocking the Potential of Targeting the Innate Immune Syste...
Ready to Catalyze the Next Wave of Inflammasome Therapies?

The Inaugural Market Access for CNS Therapeutics Summit Has ...
The only dedicated forum focused on tackling the unique commercial and reimbursement challenges facing treatments for neurodegeneration...